Association of Brain Atrophy With Functional Outcome and Recovery Trajectories After Thrombectomy: Post-Hoc Analysis of the ESCAPE-NA1 Trial
Citation Manager Formats
Make Comment
See Comments
Abstract
Background and Objectives Brain frailty may impair the ability of acute stroke patients to cope with the injury, irrespective of their chronological age, resulting in impaired recovery. We aim to investigate the impact of brain atrophy on functional outcome assessed at different time points after EVT.
Methods In this retrospective post-hoc analysis of the ESCAPE-NA1-trial, we analyzed CT-imaging data for cortical atrophy by using the GCA-scale, including region-specific scales, and subcortical atrophy by using the intercaudate-distance-to-inner-table-width (CC/IT)- ratio. The primary outcome was 90-day-mRS (ordinal-shift-analysis) and the secondary outcome was the mRS-score over time. Adjustments were made for age, sex, baseline-NIHSS, final infarct volume, stroke laterality, total Fazekas score and nerinetide-alteplase interaction. Sensitivity analyses were additionally performed in only those patients for whom MRI-data were available.
Results Out of 1,102 participants (mean age of 69.5±13.7 years;554 men), 818 (74%) had GCA=0, 220 (20%) had GCA=1 and 64 (6%) GCA=2/3. The median CC/IT-ratio was 0.12(IQR0.10-0.15). Cortical atrophy(GCA≥1 vs GCA-0) was associated with worse 90-day-mRS (acOR=1.62[95%CI:1.22-2.16]; p=001), lower rates of 90-day-mRS0-2 (aOR=0.65[95%CI:0.45-0.94]; p=0.022) and higher mortality (aOR=2.12[95%CI:1.28-3.5]; p=0.003), regardless of the region assessed. Subcortical atrophy was associated with worse 90-day-mRS(acOR[per 0.01 increase in CC/IT-ratio]=1.07[95%CI:1.04-1.11]; p<0.001) and lower rates of 90-day mRS0-2(aOR=0.92[95%CI:0.88-0.97]; p=0.001). Furthermore, with various degrees of atrophy, we observed heterogeneity in mRS-measurements during follow-up: worse mRS scores for higher atrophy grades(p<0.001). Compared to participants with GCA=0, the mRS for participants with GCA=1 was higher at 30-days (adjusted-difference=0.41[95%CI:0.18-0.65]) and remained worse at 90-days (adjusted-difference=0.72[95%CI:0.49-0.95]). Similar effects were seen for participants with worse cortical atrophy, regardless of the region assessed, and worse subcortical atrophy. Furthermore, 26/63(41%) and 124/274(45%) of patients with severe cortical/subcortical atrophy (GCA-2/-3 and highest CC/IT-ratio quartile, respectively) achieved good functional outcome(mRS0-2), compared to 539/812(66.4%) with no cortical atrophy and 209/274(76%) in the lowest CC/IT-ratio quartile.
Discussion In this large RCT-derived population, participants with brain atrophy, as visually assessed on acute NCCT-imaging, showed less favorable stroke recovery after EVT and worse 90-day functional outcomes compared to participants without brain atrophy. This may support physicians with recovery expectations when planning post-EVT care with patients and their families.
- Received October 1, 2022.
- Accepted in final form June 9, 2023.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.